StockTipsArenaBeta

SELL Cohance Lifesciences Limited — ICICI Securities

SELLCohance Lifesciences Limited
Cohance Lifesciences share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)6 Aug 2026via Moneycontrol Broker Research

Entry₹438.9Inferred
Target₹365
Total upside +16.84%
Stop lossNot given
CMP₹449.8523h ago
Active-2.49%+18.86%upside left 10 mo left
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch COHANCE for new buy/sell callsGet alertsSee 3 other Long-term calls on COHANCESee 274 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 24 Oct, 3:58 pm IST
4 supporting5 neutral7 opposing
Supports the SELL call (4)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·23 Oct · yesterday

Neutral / worth noting (5)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company.

BSE · Company Update·9 Oct · 2w ago

(opens in new tab)

Mr. Abhimanyu Ojha has been appointed as the Chief Financial Officer of the company effective October 12, 2026.

NSE · Appointment·9 Oct · 2w ago

(opens in new tab)
Weighs against the SELL call (7)

3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·21 Oct · 3d ago

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·18 Aug · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Cohance Lifesciences

All analyst calls on Cohance Lifesciences

More from ICICI Securities

Every call and its outcome